IRVINE, Calif., January 07, 2026--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, ...

On March 22, 2024, Masimo MASI Corporation (NASDAQ NDAQ: MASI, $144.91, Market Capitalisation: $7.7 billion), a global leader in non-invasive monitoring technologies and audio products, announced that ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at ...

Masimo (MASI +4%) is making a strong move following news late Friday its board authorized management to evaluate a proposed separation of its consumer business. MASI also reaffirmed its Q1 and FY24 ...

Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of ...

Files Revised Definitive Proxy Materials and Mails Letter to Stockholders Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy ...

Masimo (MASI) is back in focus after recent trading left the shares around US$138.92, with returns that differ sharply across time frames, from a small move over the past month to a deeper decline ...

Masimo Corp., an Irvine medical device maker, outlined terms of its pending initial public offering on Friday. Masimo, whose offerings include a device that measures a patient’s oxygen level, said it ...

Joe Kiani Chairman/CEO Masimo Corp. Masimo Corp. has postponed its July 25 shareholder vote that will determine control of the medical device maker and the future of founder Joe Kiani. Activist ...

Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...

Masimo has received a go-ahead from its board of directors to carve out its consumer-focused businesses, slimming itself down to focus on professional patient monitoring devices and telehealth ...